|
8,10,12,14,19-Docosapentaenoic acid, 7,16,17-trihydroxy-, (7S,8E,10Z,12E,14E,16R,17S,19Z)- Suppliers list
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:Resolvin D2 n-3 DPA
CAS:2093111-29-4
Purity:98% Package:10μg;25μg;50μg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Resolvin D2 n-3 DPA
CAS:2093111-29-4
Package:50μg/RMB 11900
|
| Company Name: |
|
| Tel: |
4008-099-669 |
| Email: |
23419001name@qq.com |
| Products Intro: |
Product Name:Resolvin D2 n-3 DPA
CAS:2093111-29-4
|
| Company Name: |
Cayman Chemical Company
|
| Tel: |
(800) 364-9897 |
| Email: |
cayman@caymanchem.com |
| Products Intro: |
Product Name:Resolvin D2 n-3 DPA
CAS:2093111-29-4
|
8,10,12,14,19-Docosapentaenoic acid, 7,16,17-trihydroxy-, (7S,8E,10Z,12E,14E,16R,17S,19Z)- manufacturers
- Resolvin D2 n-3 DPA
-
- $1710.00 / 50μg
-
2024-10-28
- CAS:2093111-29-4
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | 8,10,12,14,19-Docosapentaenoic acid, 7,16,17-trihydroxy-, (7S,8E,10Z,12E,14E,16R,17S,19Z)- Basic information |
| Product Name: | 8,10,12,14,19-Docosapentaenoic acid, 7,16,17-trihydroxy-, (7S,8E,10Z,12E,14E,16R,17S,19Z)- | | Synonyms: | 8,10,12,14,19-Docosapentaenoic acid, 7,16,17-trihydroxy-, (7S,8E,10Z,12E,14E,16R,17S,19Z)-;Resolvin D2 n-3 DPA | | CAS: | 2093111-29-4 | | MF: | C22H34O5 | | MW: | 378.5 | | EINECS: | | | Product Categories: | | | Mol File: | 2093111-29-4.mol |  |
| | 8,10,12,14,19-Docosapentaenoic acid, 7,16,17-trihydroxy-, (7S,8E,10Z,12E,14E,16R,17S,19Z)- Chemical Properties |
| Boiling point | 607.6±55.0 °C(Predicted) | | density | 1.087±0.06 g/cm3(Predicted) | | storage temp. | -80°C | | solubility | Ethanol: 1 mg/ml | | pka | 4.76±0.10(Predicted) |
| | 8,10,12,14,19-Docosapentaenoic acid, 7,16,17-trihydroxy-, (7S,8E,10Z,12E,14E,16R,17S,19Z)- Usage And Synthesis |
| Biological Activity | Resolvin D2 n-3 DPA (RvD2 n-3 DPA) is a specialized pro-resolving mediator (SPM).1 It is formed from docosapentaenoic acid , an intermediate in the conversion of eicosapentaenoic acid to docosahexaenoic acid , in human leukocytes. RvD2 n-3 DPA (1 nM) reduces TNF-α-induced chemotaxis and adhesion of isolated human neutrophils. In vivo, RvD2 n-3 DPA (100 ng/animal; i.v.) reduces peritoneal neutrophil infiltration and exudate levels of IL-6 and chemokine (C-C motif) ligand 2 (CCL2) in a mouse model of zymosan-induced inflammation. | | References | 1.Dalli, J., Colas, R.A., and Serhan, C.N.Novel n-3 immunoresolvents: Structures and actionsSci. Rep.31940(2013) |
| | 8,10,12,14,19-Docosapentaenoic acid, 7,16,17-trihydroxy-, (7S,8E,10Z,12E,14E,16R,17S,19Z)- Preparation Products And Raw materials |
|